GSK3B and neuroblastoma: Our findings are consistent with earlier work from Jimenez et al. (2011), who showed that in neuroblastoma N2a cells APPsα activates the Akt/GSK3β pathway in a mechanism involving insulin receptor (IR) or insulin like growth factor receptor (IGF-1R).